Reovirus type 1, known to be a cause of systemic and intestinal disease in mice, is secreted into the bile of adult A/J mice after viremia. Virus found in the bile in concentrations higher than those in blood may indicate that reovirus type 1 is actively transported into the bile. The transport of virus was independent of levels of virus-specific immunoglobulin A antibody. Modifications of the virus that occurred during transport did not discernibly affect the infectivity of the virus. Entry of virus into the bile may be an important mechanism by which an enteric virus that produces systemic disease reenters the intestine for transmission.
Several viruses that cause systemic disease enter the host via the gastrointestinal tract. These include the picornaviruses, such as poliovirus and hepatitis A virus, coronaviruses, and the reoviruses. Although these viruses have specific target organs, such as the liver for hepatitis A virus, they are also recoverable from feces, and it is their presence in feces that accounts for the transmission of these agents. To determine how virus is shed into the intestinal lumen during the systemic phase of illness, we studied reovirus infection in the mouse.
Our studies with reovirus type 1 strain Lang (reovirus type 1/L) demonstrate that after peroral inoculation of adult A/J mice, the only cells infected in the intestine are the epithelial cells in the ileum (16, 19, 20) . However, 24 h after intravenous (i.v.) inoculation, the highest titer of virus was present in the lumen of the duodenum (3.45 + 0.49 [standard error] log10 PFU) (15) . This finding suggests that reovirus type 1 enters the lumen of the upper bowel by a mechanism other than infection of epithelial cells. We hypothesized that the virus might enter the lumen by a secretory mechanism and tested this hypothesis by collecting and determining the titer of bile from adult A/J mice after i. (17) .
Virus. Reovirus type 1/L and reovirus type 3/D were previously described (4 Titration of virus from mouse fluids. Bile was collected for virus titration in half-hourly aliquots. Blood was collected within 5 min of virus inoculation and at the conclusion of the experiment. Specimens of blood and bile were measured, diluted 1 to 5 with saline containing gelatin, and stored at -70°C until titers were determined. Specimens of intestinal tissues were collected and assayed as previously described (16) . Briefly, mice were killed 3 to 4 h after virus inoculation, and organs were collected for virus titration. The small intestine from the gastroduodenal junction to the ileocecal valve was removed and divided into proximal, middle, and distal segments approximating duodenum, jejunum, and ileum. The cecum and colon were assayed for virus. The lumen of each bowel segment was washed with 1 ml of saline containing gelatin which was collected into a sample vial. Each segment was then placed into 1 ml of saline containing gelatin. All samples of intestinal contents were frozen and thawed three times. Tissue samples were disrupted by ultrasound (Branson Ultrasonic 200) and assayed on L-cell monolayers in 12-well cluster plates (Costar, Cambridge, Mass.). Direct comparisons between the titers of virus obtained from the intestinal contents and from tissues are not possible owing to the necessity of diluting the contents of the lumen in the process of collection and to the lack of a measurable quantity of protein in the lumenal contents.
Collection of bile. Mice were anesthetized with pentobarbital sodium, and the common bile duct was ligated at the site of insertion into the duodenum. The gallbladder was freed from its supporting ligaments and cannulated with PE-10 tubing (Clay Adams, Parsippany, N.J.). After gallbladder cannulation, the mice were hydrated by subcutaneous inoculation of 0.5 ml each of 0.9 M NaCl and 5% glucose. Protein concentration of intestinal specimens. The concentration of protein in intestinal specimens was determined by the method of Lowry et al. (6) .
RESULTS
To determine whether reovirus was present in the bile immediately after the initiation of viremia, three to five mice were inoculated i.v. with 109 PFU after cannulation of the gallbladder. Reovirus type 1/L appeared in the bile at 0.5 h after inoculation, and the titer of virus reached a steady state within 2 to 3 h after inoculation. The concentration of reovirus type 1/L recovered from the blood was approximately 1 log less than its concentration in the bile at similar time points (Fig. 1) . Furthermore, the presence of the virus in the bile remained at a steady state throughout the viremia (Fig. 1) . These findings suggest that the virus is actively transported into the bile against a concentration gradient.
Since reovirus type 1/L specifically infects the ileum, we next determined whether reovirus type 1/L had an enterohepatic circulation by inoculating mice intralumenally directly into a duodenal loop with 109 PFU of reovirus type 1/L. We were not able to recover virus in the bile during the first 12 h after infection. However, from 12 to 24 h, two of eight mice had evidence of virus in the bile. Thus, low levels of virus were found in some mice during the first 24 h after gut administration of virus.
Several studies found that dimeric immunoglobulin A (IgA) is associated with the clearance of antigens from systemic circulation by cotransport through the liver (2, 11), and it was hypothdsized that for antigens that enter systemic circulation, antigen-antibody complexes are important in antigen removal. To determine whether the mechanism of virus secretion into the bile involves cotransport of virus in immune complexes, we used a standard solid-phase enzymelinked immunosorbent assay for the detection of antireovirus antibodies (17) . No virus-specific IgA was detected in the bile, indicating that antibodies are not critically involved in this system.
Modification of the antigen may occur during processing within the liver cell before the secretion of virus into the bile (13) . Previous studies with several different viruses suggested that high levels of virus are required for uptake by liver cells with subsequent infection of the hepatocyte, further suggesting that each virus is either sequestered or modified before entry into the hepatocyte (7, 8) . It is, therefore, possible that by measuring only infectious particles, only a small fraction of the viral antigen was being assayed in the bile. To evaluate whether reovirus type 1/L may be modified to a noninfectious form, we compared the concentration of infectious virus with the total concentration of virus particles by using virus radiolabeled with [3H]uridine. The presence of radiolabeled virus in the bile reached a steady state at approximately 2 h after infection, and the calculated particle-to-PFU ratio was similar to that of the input inoculum (data not shown).
Bile accounts for only a fraction of the total volume of fluid secreted into the lumen of the intestine. The remainder of intestinal lumenal fluid is derived from sources such as saliva, gastric juice, pancreatic juice, and crypt cells. To examine whether biliary secretion accounted for the entire amount of infectious reovirus present in the intestinal lumen after i.v. inoculation, the contents of the intestinal lumen were titered for infectious virus after the bile was collected (Table 1) . After common bile duct ligation, reovirus type 1/L was present within the lumen in all segments of the bowel and was distributed to segments of the intestine as previously reported at 24 h after infection (15) .
To determine whether the entry of reovirus type 1/L into the bile was a property shared by other reovirus types, we tested reovirus type 3/D. Previous studies with reovirus type 3/D showed that it does not infect the ileum of the mouse (15) . Our findings were consistent with this; i.e., when reovirus type 3/D was given i.v., no infectious virus was found in the secretion in any bowel segmhent. If a secretory mechanism is involved in the entry of virus into the lumen of the intestine during viremia, we would predict that reovirus type 3/D would not be present in the bile. This was found to be the case. In mice inoculated i.v. with reovirus type 3/D, no infectious virus was found in the bile during the first 6 h after virus inoculation. Additionally, when tritiated uridine was used to label the reovirus type 3/D genome, there was no evidence of reovirus particles in the bile after i.v. inoculation. Finally, to determine whether the absence of infectious virus in the bile was due to a direct effect of bile on reovirus infectivity, purified reovirus types 1/L and 3/D were incubated with bile for 1 h at 37°C. There was no decrease in infectious virus after bile incubation compared with untreated controls. Thus, reovirus type 3/D is not recoverable from bile in an infectious or noninfectious form.
DISCUSSION
We examined whether reovirus type 1/L entered the gastrointestinal lumen by a secretory mechanism. It was found that infectious reovirus type 1/L appeared in the bile (9, 10) . It is probable that reovirus type 3 binds to the duct epithelium through virus-specific receptors (3) that are not shared by reovirus type 1. The mechanisms of secretion of the virus may therefore be shared by types of reovirus, but the ability to recover virus in an infectious form may differ owing to virus tropism to liver cell-binding sites. Further work is needed to establish the mechanism of elimination of reovirus type 3.
Although much information now exists on the transport mechanisms of selected substances, such as dimeric IgA, horseradish peroxidase, and certain bile acids, our understanding of hepatocellular transport is incomplete (1, 14) . Our studies indicate that pathogenic organisms can enter the bile directly, as opposed to entering the lumen by infection of either hepatocytes or biliary lining cells or as complexes associated with dimeric IgA. Thus, the development of a full understanding of the consequences of the transport of virus in secretions such as bile may directly influence our capacity to control the spread of viruses that cause systemic infection.
